A cluster randomised controlled trial protocol of an adapted intervention for alcohol use disorders in people living with HIV and AIDS: Impact on alcohol use, general functional ability, quality of life and adherence to HAART

BMC Psychiatry

Volumn 17, Issue 1, 2017, Pages

  Madhombiro, Munyaradzi ^a,b   Dube Marimbe, Bazondlile ^a   Dube, Michelle ^a   Chibanda, Dixon ^a,b   Zunza, Moleen ^c   Rusakaniko, Simbarashe ^a   Stewart, David ^d   Seedat, Soraya ^c  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^b HARARE CENTRAL HOSPITAL   (Zimbabwe)

^c UNIVERSITY OF STELLENBOSCH   (South Africa)

^d SEATTLE PACIFIC UNIVERSITY   (United States)

Author keywords

Alcohol use disorders; Cognitive behavioural therapy; Intervention; Motivational interviewing; Zimbabwe

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALCOHOL CONSUMPTION; ALCOHOL USE DISORDER IDENTIFICATION TEST; ALCOHOLISM; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL EFFECTIVENESS; COGNITIVE BEHAVIORAL THERAPY; CONTROLLED STUDY; DISEASE ASSESSMENT; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEDICATION COMPLIANCE; MENTAL HEALTH CARE; MOTIVATIONAL INTERVIEWING; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PEOPLE LIVING WITH HIV INFECTION/AIDS; POSTTRAUMATIC STRESS DISORDER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SOCIAL ENVIRONMENT; SOCIAL SUPPORT; VIRUS LOAD; WORLD HEALTH ORGANISATION DISABILITY ASSESSMENT; WORLD HEALTH ORGANIZATION; ZIMBABWE; ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ALCOHOL-RELATED DISORDERS; CLINICAL TRIAL; CLUSTER ANALYSIS; COGNITIVE THERAPY; DAILY LIFE ACTIVITY; DRINKING BEHAVIOR; EARLY INTERVENTION; HIV INFECTIONS; MULTICENTER STUDY; PILOT STUDY; PROCEDURES; PSYCHOLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ACTIVITIES OF DAILY LIVING; ADULT; ALCOHOL DRINKING; ALCOHOL-RELATED DISORDERS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CLUSTER ANALYSIS; COGNITIVE THERAPY; EARLY MEDICAL INTERVENTION; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; PILOT PROJECTS; QUALITY OF LIFE; ZIMBABWE;

EID: 85010669541     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-017-1208-3     Document Type: Article

References (62)

1. Organization WH. International guide for monitoring alcohol consumption and related harm. 2000.
2. Collins PY, Patel V, Joestl SS, et al. Grand challenges in global mental health. Nature. 2011;475(475):27-30.
3. Organization WH. Global status report on alcohol 2004. 2004.
4. Braithwaite RS, Conigliaro J, Roberts MS, Shechter S, Schaefer A, McGinnis K, et al. Estimating the impact of alcohol consumption on survival for HIV+ individuals. AIDS Care. 2007;19(4):459-66.
5. Samet JH, Freedberg KA, Savetsky JB, Sullivan LM, Stein MD. Understanding delay to medical care for HIV infection: the long-term non-presenter. AIDS. 2001;15(1):77-85.
6. Mayston R, Lazarus A, Patel V, Abas M, Korgaonkar P, Paranjape R, et al. Pathways to HIV testing and care in Goa, India: exploring psychosocial barriers and facilitators using mixed methods. BMC Public Health. 2016;16(1):765.
7. Justice AC, McGinnis KA, Tate JP, Braithwaite RS, Bryant KJ, Cook RL, et al. Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men. Drug Alcohol Depend. 2016;161:95-103.
8. Hahn JA, Woolf-King SE, Muyindike W. Adding fuel to the fire: alcohol's effect on the HIV epidemic in Sub-Saharan Africa. Curr HIV/AIDS Rep. 2011;8(3):172-80.
9. Kalichman SC, Simbayi LC, Jooste S, Cain D. Frequency, quantity, and contextual use of alcohol among sexually transmitted infection clinic patients in Cape Town, South Africa. Am J Drug Alcohol Abuse. 2007;33(5):687-98.
10. Starace F, Ammassari A, Trotta MP, Murri R, De Longis P, Izzo C, et al. Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31(Suppl 3):S136-9.
11. Willie TC, Overstreet NM, Sullivan TP, Sikkema KJ, Hansen NB. Barriers to HIV medication adherence: examining distinct anxiety and depression symptoms among women living with HIV who experienced childhood sexual abuse. Behav Med. 2015;42(2):120-7.
12. Stevens VM, Neel JL, Baker DL. Psychosis and nonadherence in an HIV-seropositive patient. AIDS Read. 2000;10(10):596-601.
13. Wu ES, Metzger DS, Lynch KG, Douglas SD. Association between alcohol use and HIV viral load. J Acquir Immune Defic Syndr. 2011;56(5):e129-30.
14. Molina PE, Happel KI, Zhang P, Kolls JK, Nelson S. Focus on: Alcohol and the immune system. Alcohol Res Health. 2010;33(1-2):97-108.
15. Pandrea I, Happel KI, Amedee AM, Bagby GJ, Nelson S. Alcohol's role in HIV transmission and disease progression. Alcohol Res Health. 2010;33(3):203-18.
16. Theall KP, Amedee A, Clark RA, Dumestre J, Kissinger P. Alcohol consumption and HIV-1 vaginal RNA shedding among women. J Stud Alcohol Drugs. 2008;69(3):454-8.
17. Tran BX, Nguyen LT, Do CD, Nguyen QL, Maher RM. Associations between alcohol use disorders and adherence to antiretroviral treatment and quality of life amongst people living with HIV/AIDS. BMC Public Health. 2014;14:27.
18. Morojele NK, Kekwaletswe CT, Nkosi S. Associations between alcohol use, other psychosocial factors, structural factors and antiretroviral therapy (ART) adherence among South African ART recipients. AIDS Behav. 2014;18(3):519-24.
19. Valenti WM. HAART is cost-effective and improves outcomes. AIDS Read. 2001;11(5):260-2.
20. Holmes WC, Bilker WB, Wang H, Chapman J, Gross R. HIV/AIDS-specific quality of life and adherence to antiretroviral therapy over time. J Acquir Immune Defic Syndr. 2007;46(3):323-7.
21. Neuman MG, Cohen L, Zakhari S, Nanau RM, Mueller S, Schneider M, et al. Alcoholic liver disease: a synopsis of the Charles Lieber's Memorial Symposia 2009-2012. Alcohol Alcohol. 2014;49(4):373-80.
22. Schneider M, Chersich M, Temmerman M, Degomme O, Parry CD. The impact of alcohol on HIV prevention and treatment for South Africans in primary healthcare. Curationis. 2014;37(1):1137.
23. Morojele NK, Kachieng'a MA, Mokoko E, Nkoko MA, Parry CD, Nkowane AM, et al. Alcohol use and sexual behaviour among risky drinkers and bar and shebeen patrons in Gauteng province, South Africa. Soc Sci Med. 2006;62(1):217-27.
24. Baker A, Lee NK, Claire M, Lewin TJ, Grant T, Pohlman S, et al. Brief cognitive behavioural interventions for regular amphetamine users: a step in the right direction. Addiction. 2005;100(3):367-78.
25. Naicker S, Eastwood JB, Plange-Rhule J, Tutt RC. Shortage of healthcare workers in sub-Saharan Africa: a nephrological perspective. Clin Nephrol. 2010;74(Suppl 1):S129-33.
26. Sander LD, Holtzman D, Pauly M, Cohn J. Time savings--realized and potential--and fair compensation for community health workers in Kenyan health facilities: a mixed-methods approach. Hum Resour Health. 2015;13:6.
27. Deller B, Tripathi V, Stender S, Otolorin E, Johnson P, Carr C. Task shifting in maternal and newborn health care: key components from policy to implementation. Int J Gynaecol Obstet. 2015;130(Suppl 2):S25-31.
28. Lehmann U, Van Damme W, Bartn F, Sanders D. Task shifting: the answer to the human resources crisis in Africa? Hum Resour Health. 2009;7:49.
29. Adams JL, Almond ML, Ringo EJ, Shangali WH, Sikkema KJ. Feasibility of nurse-led antidepressant medication management of depression in an HIV clinic in Tanzania. Int J Psychiatry Med. 2012;43(2):105-17.
30. Wagner GJ, Ngo V, Glick P, Obuku EA, Musisi S, Akena D. INtegration of DEPression Treatment into HIV Care in Uganda (INDEPTH-Uganda): study protocol for a randomized controlled trial. Trials. 2014;15:248.
31. Mental health: WHO minds the GAP. Lancet. 2010;376(9749):1274.
32. Babor TF, De la Fuente JR, Saunders JB, Grant M. AUDIT-the alcohol use disorders identification test: guidelines for use in primary health care. Geneva: World Health Organization; 1989b.
33. Chandiwana SK, Sebit MB, Latif AS, Gomo E, Acuda SW, Makoni F, et al. Alcohol consumption in HIV-I infected persons: a study of immunological markers, Harare, Zimbabwe. Cent Afr J Med. 1999;45(11):303-8.
34. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Arch Intern Med. 1998;158(16):1789-95.
35. Üstün TB, Chatterji S, Villanueva M, Bendib L, Celik C, Sadana R, et al. WHO Multi-country Survey Study on Health and Responsiveness 2000-2001. In: Murray CJL, Evans DB, eds. Health systems performance assessment: debates, methods and empiricism. Geneva: World Health Organization; 2003. p. 761-96.
36. Hanass-Hancock J, Myezwa H, Carpenter B. Disability and living with HIV: baseline from a cohort of people on long term ART in South Africa. PLoS One. 2015;10(12):e0143936.
37. WHOQOL Group. The development of the World Health Organization Quality of Life Assessment Instrument (the WHOQOL). In: Orley J, Kuyken W, editors. Quality of life assessment: international perspectives. New York:Springer-Verlag; 1994.
38. Peltzer K, Phaswana-Mafuya N. Health-related quality of life in a sample of HIV-infected South Africans. Afr J AIDS Res. 2008;7(2):209-18.
39. The WHOQOL Group. Developmentof the World Health Organization WHOQOL-BEFquality of life assessment. Psychol Med. 1998;28:551-8.
40. Berman AH, Bergman H, Palmstierna T, Schlyter F. DUDIT - The drug use disorders identification test, MANUAL Version 1.0. Stockholm: Karolinska Institutet, Department of Clinical Neuroscience, Section for Alcohol and Drug Dependence Research; 2003.
41. Berman AH, Bergman H, Palmstierna T, Schlyter F. Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res. 2005;11(1):22-31.
42. Durbeej N, Berman AH, Gumpert CH, Palmstierna T, Kristiansson M, Alm C. Validation of the alcohol use disorders identification test and the drug use disorders identification test in a Swedish sample of suspected offenders with signs of mental health problems: results from the Mental Disorder, Substance Abuse and Crime study. J Subst Abuse Treat. 2010;39(4):364-77.
43. Voluse AC, Gioia CJ, Sobell LC, Dum M, Sobell MB, Simco ER. Psychometric properties of the Drug Use Disorders Identification Test (DUDIT) with substance abusers in outpatient and residential treatment. Addict Behav. 2012;37(1):36-41.
44. Whetten K, Reif S, Swartz M, Stevens R, Osterman J, Hanisch L, Eron JJ. A brief mental health and substance abuse screener for persons with HIV. AIDS Patient Care STDs. 2005;19(2):89-99.
45. Breuer E, Stoloff K, Myer L, Seedat S, Stein DJ, Joska JA. The validity of the Substance Abuse and Mental Illness Symptom Screener (SAMISS) in people living with HIV/AIDS in primary HIV care in Cape Town, South Africa. AIDS Behav. 2014;18(6):1133-41.
46. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22-33. quiz 4-57.
47. American Psychiatric Association. The diagnostic and statistical manual of mental disorders, Fifth Edition. Arlington: American Psychiatric Association; 2013.
48. Pinninti NR, Madison H, Musser E, Rissmiller D. MINI International Neuropsychiatric Schedule: clinical utility and patient acceptance. Eur Psychiatry. 2003;18(7):361-4.
49. New York State Department of Health AIDS Institute: www.hivguidelines.org. International HIV Dementia Scale (IHDS).
50. Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, McArthur JC, Ronald A, Katabira E. The international HIVDementia Scale: a new rapid screening test for HIV Dementia. AIDS. 2005;19(13):1367-74.
51. Davidson JR, Book SW, Colket JT, Tupler LA, Roth S, David D, et al. Assessment of a new self-rating scale for post-traumatic stress disorder. Psychol Med. 1997;27(1):153-60.
52. Davidson JR, Tharwani HM, Connor KM. Davidson Trauma Scale(DTS): normative scores in the general population and effect sizes in a placebo-controlled SSRI trials. Depress Anxiety. 2002;15(2):75-8.
53. Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol. 1989;56(2):267-83.
54. Valvano ASL. Critical synthesis package: brief COPEQ uestionnaire. MedEdPORTAL. 2013;9:9453.
55. Zimet GD, Powell SS, Farley GK, Werkman S, Berkoff KA. Psychometric characteristics of the multidimensional scale of perceived social support. J Pers Assess. 1990;55(3-4):610-7.
56. Backs-Dermott BJ, Dobson KS, Jones SL. An evaluation of an integrated model of relapse in depression. J Affect Disord. 2010;124(1-2):60-7.
57. Gache P, Michaud P, Landry U, Accietto C, Arfaoui S, Wenger O, et al. The Alcohol Use Disorders Identification Test (AUDIT) as a screening tool for excessive drinking in primary care: reliability and validity of a French version. Alcohol Clin Exp Res. 2005;29(11):2001-7.
58. Gearing RE, El-Bassel N, Ghesquiere A, Baldwin S, Gillies J, Ngeow E. Major ingredients of fidelity: a review and scientific guide to improving quality of intervention research implementation. Clin Psychol Rev. 2011;31(1):79-88.
59. Moyer A, Finney JW, Swearingen CE, Vergun P. Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. Addiction. 2002;97(3):279-92.
60. Killip S, Mahfoud Z, Pearce K. What is an intracluter correlation coefficient? Crucial concepts for primary care researchers. Ann Fam Med. 2004;2(3):204-8.
61. Bajunirwe F, Tisch DJ, King CH, Arts EJ, Debanne SM, Sethi AK. Quality of life and social support among patients receiving antiretroviral therapy in Western Uganda. AIDS Care. 2009;21(3):271-9.
62. Liu C, Johnson L, Ostrow D, Silvestre A, Visscher B, Jacobson LP. Predictors for lower quality of life in the HAART era among HIV-infected men. J Acquir Immune Defic Syndr. 2006;42(4):470-7.